Institutional Biosafety Committee (IBC)

Lewis & Clark’s Institutional Biosafety Policy ensures the protection of faculty, staff, students who generate, process, and dispose of potentially hazardous biological materials at Lewis & Clark, as well as others who may become exposed to biological hazards within the institutional environment. The Institutional Biosafety Committee (IBC) must review and approve all research involving recombinant DNA, synthetic nucleic acid molecules, infectious agents or toxins. The PI must submit an application to the IBC prior to research initiation. 

Current Committee Membership
Nikolaus Loening, PhD - Professor of Chemistry, IBC Chair
Helen Rappe Baggett, M.S. - Biosafety Specialist, Oregon Health & Science University
Sarah Byers, PhD - Assistant Research Integrity Officer, Oregon Health & Science University
Jason Holmgren - Occupational Health & Safety Manager
Sharon Torigoe, PhD - Assistant Professor of Biology
Administered by the Sponsored Projects and Research Compliance Office. Contact: Kelly DelFatti, Assistant VP of SPARC at sponsres@lclark.edu

Institutional Official: David Reese, Vice President, Chief of Staff, General Counsel and Board Secretary

Meeting Schedule
The IBC meets annually, usually in the spring. Minutes of IBC meetings are available upon request. Please contact sponsres@lclark.edu for more information.

Training Requirements
Research involving biological materials requires additional training. 

Forms 

Resources
The following links will take you away from the L&C website.

• NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) - Frequently Asked Questions
• Experiments that are Exempt from the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) - Frequently Asked Questions